FDA
- Status: approved
Rapid and long acting insulin (Rapid and long acting insulin) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Albert Einstein College of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.